Related Experiment Video

Updated: Jun 19, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

[Necrotizing pneumonia due to methicillin-resistant Staphylococcus aureus]

Pedro Alves d'Azevedo1, Fernanda Matsiko Inoue, Soraya Sgambatti Andrade

  • 1Laboratório Especial de Microbiologia Clínica, Universidade Federal de São Paulo, São Paulo, SP. pedro_dazevedo@yahoo.com.br

Revista Da Sociedade Brasileira De Medicina Tropical
|October 6, 2009
PubMed

Insights

Necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) was identified in a previously healthy individual. This suggests community-acquired MRSA strains can cause severe infections, necessitating increased vigilance.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Genetics

Background:

  • Severe pneumonia can arise from various pathogens, including antibiotic-resistant bacteria.
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant public health concern globally.
  • Understanding the genetic determinants of MRSA is crucial for effective treatment and control.

Observation:

  • A case of necrotizing pneumonia was described in a previously healthy patient.
  • The causative agent was identified as methicillin-resistant Staphylococcus aureus (MRSA).
  • The MRSA isolate was obtained from a blood culture within 48 hours of hospital admission.

Findings:

  • The MRSA isolate possessed the mecA gene, indicative of methicillin resistance.
  • The specific genetic makeup was characterized as staphylococcal cassette chromosome mec (SCCmec) type IVa.
  • This genetic profile suggests a potential for community-acquired severe infections.

Implications:

  • The findings highlight the potential for MRSA strains with specific genetic markers (SCCmec IVa) to cause severe community-acquired pneumonia.
  • Healthcare providers should consider MRSA in the differential diagnosis of severe pneumonia, even in seemingly healthy individuals.
  • This case underscores the importance of ongoing surveillance and characterization of MRSA isolates in clinical settings.

More Related Videos

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...